A medical device company hopes to use prescription-dispensing robots to reduce deadly errors, according to recent news reports. The company, RescueDose, is one of several developing robots to combat the deadly and disabling effects of human error.
Such errors can be caused by fatigue, staff shortages, inadequate training, and other reasons. The World Health Organization reports that medication errors harm 1.3 million annually and cause at least one death daily in the U.S. These errors also are costly at $42 billion per year.
RescueDose’s first product is the “UniDose” robot that dispenses nuclear medicine, such as for medical imaging. By automating the process, the robot reduces radiation exposure for pharmaceutical staff who would otherwise prepare the doses. The company has completed pilot studies with the University of Oklahoma, demonstrating that the technology is 95% accurate. The product is ready for market, and RescueDose plans on introducing it initially in the Far East, including China and Taiwan.
The company has a second robot, called ChemiDose, which dispenses medication for chemotherapy. The robot can prepare ready-to-use IV bags using powder or liquid medications. It is still in development and not yet ready for market.
Many cases alleging medical negligence or malpractice can be complicated; successful suits require an experienced eye. If you would like to talk to an attorney experienced in medical malpractice, please reach out to us. Our firm is recognized as a leader in litigating injury cases throughout Pennsylvania.